Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells.

Miller MJ, Foy KC, Overholser JP, Nahta R, Kaumaya PT.

Oncoimmunology. 2014 Dec 21;3(11):e956012. eCollection 2014 Nov.

2.

Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivo.

Foy KC, Wygle RM, Miller MJ, Overholser JP, Bekaii-Saab T, Kaumaya PT.

J Immunol. 2013 Jul 1;191(1):217-27. doi: 10.4049/jimmunol.1300231. Epub 2013 May 22.

3.

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, Thorpe PE.

Cancer Res. 2000 Sep 15;60(18):5117-24.

4.

Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice.

Overholser JP, Prewett MC, Hooper AT, Waksal HW, Hicklin DJ.

Cancer. 2000 Jul 1;89(1):74-82.

PMID:
10897003
5.

Potent antitumor effects of an antitumor endothelial cell immunotoxin in a murine vascular targeting model.

Burrows FJ, Overholser JP, Thorpe PE.

Cell Biophys. 1994;24-25:15-25.

PMID:
7736519

Supplemental Content

Loading ...
Support Center